Northpond Ventures III GP, LLC
SEC CIK 2010695 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | Former 10% Owner | 450.0K | $9.90M | — | 2 | 2024-02-12 | 2024-02-12 |
Most active insiders at KYTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Westlake BioPartners Opportunity Fund I, L.P. | 10% | $1000.0K | — |
| 2 | SEIDENBERG BETH C | Dir | $1000.0K | — |
| 3 | Walker Karen Marie | CTO | — | $292.8K |
| 4 | GEHCHAN NAJI | See Remarks | — | — |
| 5 | Aktar Mert | Dir | — | — |
| 6 | Biddle Warner Weston | CEO, Dir | — | — |
| 7 | Emany Sravan Kumar | Dir | — | — |
| 8 | Miller Andrew Craig | Dir | — | — |
| 9 | GRASSO MARC | CFO | — | — |
| 10 | Shaw Christi | Executive COB, Dir | — | — |
Northpond Ventures III GP, LLC made no open-market trades at KYTX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-02-12 | 2024-02-12 | KYTX | Kyverna Therapeutics, Inc. | Northpond Ventures III GP, LLC | Former 10% Owner | P - Purchase | $22.00 | +450.0K | 450.0K | New | +$9.90M |
| DI | 2024-02-12 | 2024-02-12 | KYTX | Kyverna Therapeutics, Inc. | Northpond Ventures III GP, LLC | Former 10% Owner | C - Cnv Deriv | — | +2.81M | 2.81M | New | — |
Purchase Sale Sale after option exercise All abbreviations